Volume 2007, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426


Objective: The purpose of this study is to evaluate the risk of foetal loss attributable to amniocentesis and to assess the experience in technique, successful fluid aspiration in amniocentesis performed in our hospital Study Design: Medical record of 123 women who underwent amniocentesis between September 1996 till March 2002 were reviewed for indication, maternal, age, nationality, maternal age, parity, nationality, gestational age at procedure, physician operator, amniotic fluid reports and pregnancy outcome.

Result: Within 30 days of amniocentesis there were tow (2.2%) foetal lossess, 91 patients (74%) for genetic amniocentesis, 32 patients (26%) Rh. Isoimmunization, 4 cases (3.2%) no fluid aspiration and in 10 patients procedure repeated one week later for successful aspiration.

Conclusion: Amniocentesis-related total pregnancy loss rate was 2.2%. Successful aspiration of clear amniotic fluid increases with amniocentesis experience.


Article metrics loading...

Loading full text...

Full text loading...


  1. NICHD, National institute of child health and Human Development National Registery for Amniocentesis Study Group. Midtrimester amniocentesis for prenatal diagnosis: Safety and accuracy. Jama. 1976; 236::14711476, abstract.
    [Google Scholar]
  2. Canadian early and Midtrimester Amniocentesis trial (CEMAT) group. Randomized trial to assess the safety and fetal outcomes of early and midtrimester amniocentesis. Lancet. 1998; 351::242247, abstract.
    [Google Scholar]
  3. Tabor A, Madsen M, Obel EB, Philip J, Bang J, Norgaard-Pedersen B. Randomized controlled trial of genetic amniocentesis in 4606 low- risk women. Lancet. 1986; 1::12871293.
    [Google Scholar]
  4. Silver RK, Russel TL, Kambich MP, Leeth EA, MacGregor SN, Sholl JS. Midtrimester amniocentesis: influence of operator caseload on sampling efficiency. J. Reported Med. 1998; 43::191195.
    [Google Scholar]
  5. Marthin T, Leidgren S, Hammar M. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis. Acta Obstet gynecol Scand. 1997; 76::728732.
    [Google Scholar]
  6. Leshchot NJ, Verhjall M, Treffers PE. Risks of midtrimester amniocentesis; assessment in 3000 pregnencies. BJOG. 1985; 92::804807.
    [Google Scholar]
  7. Blessed WB, Lacoste H, Welch RA. Obstetrician-gynecologists performing genetic amniocentesis may be misleading themselves and their patients. Am J obset gynecol. 2001; 184::13401344, full text.
    [Google Scholar]
  8. Liley AW. Liquor amnii analysis in management of pregnancy complicated by rhesus sensitization. Am J. Obset Gynecol. 1961; 82::13591370.
    [Google Scholar]
  9. Hanson FW, Tenant FR, Zorn EM, Samuels S. Analysis of 236 genetic amniocentesis; experience of single physician. Am J Obstet Gynecol. 1985;:152436152443.
    [Google Scholar]
  10. Golbus MS, Loughman WD, Epstein CJ, Halbasch G, Stephens JD, Hall BD. Prenatal genetic diagnosis in 3000 amniocentesis. N Engl J Med. 1979; 300::157163.
    [Google Scholar]
  11. Zorn EM, Hanson FW, Greve LC, Phelps-Sandall B, Tennant FR. Analysisis of the significance of discolored amniotic fluid detectedd at midtrimetser amniocentesis. Am J Obstet Gynecol. 1986; 154:12341240.
    [Google Scholar]
  12. Sean C Blackwell, Margot G Abundis, Paul C Nehra. Five year experience with midtrimester amniocentesis performed by a single group of obstericians-gynecologists at a community hospital. AM J Obstet Gyne. 2002;:186.
    [Google Scholar]
  13. Edgar O, Horger 111, Holmes Finch MEd, Victoria A. Vincent, A single physician's experience with four thousanf six hundred genetic amniocentesis. AM J Obstet Gynecol. 2001;:279288.
    [Google Scholar]
  • Article Type: Research Article
Keyword(s): Amniocentesispregnancy loss rateprenatal diagnosis and Rh isoimmunization
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error